Changes in QRS Area and QRS Duration After Cardiac Resynchronization Therapy Predict Cardiac Mortality, Heart Failure Hospitalizations, and Ventricular Arrhythmias.
Osita Okafor,Abbasin Zegard,Peter van Dam,Berthold Stegemann,Tian Qiu,Howard Marshall,Francisco Leyva
DOI: https://doi.org/10.1161/JAHA.119.013539
IF: 6.106
2019-11-26
Journal of the American Heart Association
Abstract:Background Predicting clinical outcomes after cardiac resynchronization therapy (CRT) and its optimization remain a challenge. We sought to determine whether pre‐ and postimplantation QRS area (QRS area ) predict clinical outcomes after CRT. Methods and Results In this retrospective study, QRS area , derived from pre‐ and postimplantation vectorcardiography, were assessed in relation to the primary end point of cardiac mortality after CRT with or without defibrillation. Other end points included total mortality, total mortality or heart failure (HF) hospitalization, total mortality or major adverse cardiac events, and the arrhythmic end point of sudden cardiac death or ventricular arrhythmias with or without a shock. In patients (n=380, age 72.0±12.4 years, 68.7% male) undergoing CRT over 7.7 years (median follow‐up: 3.8 years [interquartile range 2.3–5.3]), preimplantation QRS area ≥102 μVs predicted cardiac mortality (HR: 0.36; P <0.001), independent of QRS duration (QRSd) and morphology ( P <0.001). A QRS area reduction ≥45 μVs after CRT predicted cardiac mortality (HR: 0.19), total mortality (HR: 0.50), total mortality or heart failure hospitalization (HR: 0.44), total mortality or major adverse cardiac events (HR: 0.43) (all P <0.001) and the arrhythmic end point (HR: 0.26; P <0.001). A concomitant reduction in QRS area and QRSd was associated with the lowest risk of cardiac mortality and the arrhythmic end point (both HR: 0.12, P <0.001). Conclusions Pre‐implantation QRS area , derived from vectorcardiography, was superior to QRSd and QRS morphology in predicting cardiac mortality after CRT. A postimplant reduction in both QRS area and QRSd was associated with the best outcomes, including the arrhythmic end point. Clinical Perspective What Is New? Pre‐implantation QRS area was superior to QRSd and QRS morphology in predicting cardiac and total mortality after cardiac resynchronization therapy. Concomitant reductions in QRS area and QRSd after cardiac resynchronization therapy were associated with the best survival and the lowest risk of heart failure hospitalization, major adverse cardiac events as well as ventricular arrhythmias. What Are the Clinical Implications? Reductions in QRS area and QRSd could be a focus for optimization after cardiac resynchronization therapy implantation. Introduction Cardiac resynchronization therapy (CRT) is an established treatment for patients with heart failure (HF), impaired left ventricular (LV) function, and a wide QRS complex. 1 As with any medical therapy, its treatment effect is variable. "Nonresponder" rates range from 9% to 68%, depending on the criteria used to define response. 2 Although no medical therapy can be expected to be 100% effective, there is a consensus view that response to CRT can be improved. 3 Manifold imaging studies explored mechanical dyssynchrony in relation to patient selection and optimization but, ultimately, no single measure of mechanical dyssynchrony has been adopted by clinical guidelines. 4 In this context, we should consider CRT is an electrical treatment and that its substrate should be electrical rather than mechanical. In this respect, QRS duration (QRSd) has been adopted as a surrogate of electrical dyssynchrony in randomized, controlled trials, 1 and a reduction in QRSd has been shown to predict better long‐term outcomes after CRT. 5 , 6 Evidence has recently emerged in support of vectorcardiography in the field of CRT. In this respect, QRS area (QRS area ) has been shown to correlate with LV lateral wall activation time, 7 the maximum rate of rise of LV pressure (ΔLV dP/dt max ), 8 , 9 and LV reverse remodeling<a class="tab-li -Abstract Truncated-
cardiac & cardiovascular systems